We examined the effect of nintedanib on intracellular RTK cell-signaling components, including ERK, AKT, and STAT3 activity, which also regulate cell proliferation, inflammation, and fibrosis in ADPKD kidneys [9, 11, 23]. Here, STAT3 is linked to autosomal dominant polycystic kidney disease.